Cargando…

A phase II study of concurrent chemo-radiotherapy with weekly nedaplatin in advanced squamous cell carcinoma of the uterine cervix

BACKGROUND: To evaluate the efficacy and safety of concurrent chemo-radiotherapy with weekly nedaplatin for the treatment of advanced squamous cell carcinoma of the uterine cervix. METHODS: Patients with stage Ib2 to IIIb squamous cell carcinoma of the uterine cervix were treated with concurrent rad...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yuan, Guangwen, Wu, Lingying, Huang, Manni, Li, Nan, An, Jusheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3937080/ https://www.ncbi.nlm.nih.gov/pubmed/24533532 http://dx.doi.org/10.1186/1748-717X-9-55

Ejemplares similares

Primary malignant melanoma of the cervix: Report of 14 cases and review of literature
por: Yuan, Guangwen, et al.
Publicado: (2017)

Radiotherapy Combined With Concurrent Nedaplatin-Based Chemotherapy for Stage II–III Esophageal Squamous Cell Carcinoma
por: Zhu, Huiping, et al.
Publicado: (2022)

Concurrent chemoradiotherapy with raltitrexed and nedaplatin regimen for esophageal squamous cell carcinoma
por: Qiu, Xiangnan, et al.
Publicado: (2020)

Phase II study of nedaplatin and irinotecan with concurrent thoracic radiotherapy in patients with locally advanced non-small-cell lung cancer
por: Oshita, F, et al.
Publicado: (2010)

IMRT and HDR-ICBT for Locally Advanced Clear Cell Adenocarcinoma of the Cervix in Uterus Didelphys Associated With Unilateral Renal Agenesis
por: Lei, Chengzhi, et al.
Publicado: (2020)

Phase II study of adjuvant chemotherapy with paclitaxel and nedaplatin for uterine cervical cancer with lymph node metastasis
por: Takekuma, Munetaka, et al.
Publicado: (2018)

Evaluation of the efficacy and feasibility of concurrent weekly docetaxel-nedaplatin and hypo-fractionated radiotherapy in atypical histologic subtypes of primary and metastatic mediastinal malignancies
por: Meng, FanJun, et al.
Publicado: (2022)

Phase II Study of a Bi-Weekly Chemotherapy Regimen of Combined Liposomal Paclitaxel and Nedaplatin for the Treatment of Advanced Squamous Cell Lung Cancer
por: Lv, Wei-Ze, et al.
Publicado: (2019)

Significance of concurrent use of weekly cisplatin in carbon‐ion radiotherapy for locally advanced adenocarcinoma of the uterine cervix: A propensity score‐matched analysis
por: Okonogi, Noriyuki, et al.
Publicado: (2019)

Phase II trial of neoadjuvant chemotherapy with docetaxel, nedaplatin, and S1 for advanced esophageal squamous cell carcinoma
por: Tanaka, Yoshihiro, et al.
Publicado: (2016)

Phase II study of nedaplatin and amrubicin as first‐line treatment for advanced squamous cell lung cancer
por: Taniguchi, Hirokazu, et al.
Publicado: (2019)

Concurrent chemoradiotherapy using gemcitabine and nedaplatin in recurrent or locally advanced head and neck squamous cell carcinoma
por: Huo, Rui-Xue, et al.
Publicado: (2022)

Concurrent Weekly versus Three Weekly Cisplatin with Radiotherapy in Locally Advanced Uterine Cervical Carcinoma
por: Hasan, Md. Rakibul, et al.
Publicado: (2018)

Randomized Phase II Trial of Triapine-Cisplatin-Radiotherapy for Locally Advanced Stage Uterine Cervix or Vaginal Cancers
por: Kunos, Charles A., et al.
Publicado: (2019)

Expression of CHOP in Squamous Tumor of the Uterine Cervix
por: Chu, Hyun Hee, et al.
Publicado: (2012)

Nomograms based on HPV load for predicting survival in cervical squamous cell carcinoma: An observational study with a long-term follow-up
por: Zuo, Jing, et al.
Publicado: (2019)

Phase I trial of nedaplatin and S-1 in patients with advanced squamous cell lung cancer
por: Kanaji, Nobuhiro, et al.
Publicado: (2020)

Prognostic Nomograms Predicting Survival in Patients With Locally Advanced Cervical Squamous Cell Carcinoma: The First Nomogram Compared With Revised FIGO 2018 Staging System
por: Yang, Xi, et al.
Publicado: (2020)

History of radiotherapy in the treatment of uterine cervix cancer: an overview
por: Carvalho, Heloisa de Andrade, et al.
Publicado: (2023)

Concurrent chemo-radiotherapy with proton therapy: reduced toxicity with comparable oncological outcomes vs photon chemo-radiotherapy
por: Baumann, Brian C., et al.
Publicado: (2020)

A phase III randomized, controlled trial of nedaplatin versus cisplatin concurrent chemoradiotherapy in patients with cervical cancer
por: Yang, X., et al.
Publicado: (2022)

Hypoxia biomarkers in squamous cell carcinoma of the uterine cervix
por: Ellingsen, Christine, et al.
Publicado: (2015)

Potential new biomarkers for squamous carcinoma of the uterine cervix
por: van Dam, Peter A, et al.
Publicado: (2018)

Concurrent weekly cisplatin versus triweekly cisplatin with radiotherapy for locally advanced squamous-cell carcinoma of the cervix: a retrospective analysis from a single institution
por: Kinjyo, Yoshino, et al.
Publicado: (2017)

Phase II trial of docetaxel combined with nedaplatin for patients with recurrent and metastatic nasopharyngeal carcinoma
por: Peng, Pei-Jian, et al.
Publicado: (2015)

Comparison of treatment outcomes between squamous cell carcinoma and adenocarcinoma of cervix after definitive radiotherapy or concurrent chemoradiotherapy
por: Hu, Ke, et al.
Publicado: (2018)

Randomized Phase II Study to Comparing Docetaxel/Nedaplatin versus Docetaxel for 5-Fluorouracil/Cisplatin Resistant Esophageal Squamous Cell Carcinoma
por: Yajima, Satoshi, et al.
Publicado: (2021)

A phase II randomized trial comparing radiotherapy with concurrent weekly cisplatin or weekly paclitaxel in patients with advanced cervical cancer
por: Geara, Fady B, et al.
Publicado: (2010)

Phase I study of cisplatin analogue nedaplatin (254-S) and paclitaxel in patients with unresectable squamous cell carcinoma
por: Sekine, I, et al.
Publicado: (2004)

Results of a Phase I-II Study on Laser Therapy for Vaginal Side Effects after Radiotherapy for Cancer of Uterine Cervix or Endometrium
por: Perrone, Anna Myriam, et al.
Publicado: (2020)

Management of low-grade squamous intraepithelial lesions of the uterine cervix
por: Scheungraber, C, et al.
Publicado: (2004)

Malignancy grading in squamous carcinoma of uterine cervix treated by surgery.
por: Pagnini, C. A., et al.
Publicado: (1980)

A phase I/II study of combined weekly systemic cisplatin and locoregional hyperthermia in patients with previously irradiated recurrent carcinoma of the uterine cervix
por: Wit, R de, et al.
Publicado: (1999)

Neoadjuvant chemotherapy with docetaxel, nedaplatin, and fluorouracil for resectable esophageal cancer: A phase II study
por: Ohnuma, Hiroyuki, et al.
Publicado: (2018)

Concurrent Chemoradiotherapy With Nedaplatin Versus Cisplatin in Patients With Stage IIB-IVA Cervical Cancer: A Randomized Phase III Trial
por: He, Shasha, et al.
Publicado: (2022)

Serum tumour markers in carcinoma of the uterine cervix and outcome following radiotherapy.
por: Sproston, A. R., et al.
Publicado: (1995)

Long-term bresults of radiotherapy combined with nedaplatin and 5-fluorouracil for postoperative loco-regional recurrent esophageal cancer: update on a phase II study
por: Jingu, Keiichi, et al.
Publicado: (2012)

Dihydromyricetin Enhances the Chemo-Sensitivity of Nedaplatin via Regulation of the p53/Bcl-2 Pathway in Hepatocellular Carcinoma Cells
por: Jiang, Lianggui, et al.
Publicado: (2015)

CANCER OF THE UTERINE CERVIX
Publicado: (1973)

Cancer of the Uterine Cervix
por: Duarte-Franco, Eliane, et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_869fe2m653cesijgep2q737ome